廣譽遠(600771.SH):控股股東質押的1400萬股延期購回 補充質押150萬股
格隆匯12月25日丨廣譽遠(600771.SH)公佈,公司於2019年12月25日接到控股股東西安東盛集團有限公司關於股票質押式回購交易延期購回及補充質押的通知。
2017年12月8日,東盛集團將其持有公司的1000萬股無限售條件流通股股份與申萬宏源證券進行了為期729天的股票質押式回購交易,股票質押初始交易日為2017年12月8日,購回交易日為2019年12月7日。2019年12月20日,東盛集團將上述1400萬股無限售條件流通股股份(因股份質押期間公司發生資本公積金轉增股本事項,東盛集團所持股份數及股份質押數相應調整)辦理了延期購回交易手續。
另外,補充質押150萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.